Naturally occurring compound spermidine boosts vaccine responses in old mice
Researchers at the Kennedy Institute identify a molecular pathway to boost vaccine responses in the elderly.
Read moreA warm welcome to the Kennedy 2019 DPhil student intake
The Kennedy Institute welcomes a new intake of DPhil students supported by funders including the Kennedy Trust for Rheumatology Research, Wellcome Trust, BBSRC, British Heart Foundation and the National Institutes of Health Oxford-Cambridge.
Read moreKennedy Trust Prize Studentships
Our 4 year DPhil doctoral training programme is now open for applications.
Read moreKennedy Trust renews commitment to rheumatology research with £20M
The Kennedy Trust for Rheumatology Research (KTRR) has pledged a minimum of £20M over five years to the Kennedy Institute of Rheumatology at the University of Oxford to support pioneering research into chronic inflammatory disease.
Read moreKennedy Institute of Rheumatology
A world-leading medical research centre where discovery research drives the development of transformative therapies for chronic inflammatory and degenerative disease.
240 Staff, students and academic visitors
30 Nationalities
£70M+ in Research Income
Select Publications
Angiocrine signals regulate quiescence and therapy resistance in bone metastasis
Singh A. et al, (2019), JCI Insight, 4
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Nayar S. et al, (2019), Proc Natl Acad Sci U S A, 116, 13490 - 13497
Distinct fibroblast subsets drive inflammation and damage in arthritis.
Croft AP. et al, (2019), Nature, 570, 246 - 251
The HVEM-BTLA Axis Restrains T Cell Help to Germinal Center B Cells and Functions as a Cell-Extrinsic Suppressor in Lymphomagenesis.
Mintz MA. et al, (2019), Immunity
Latest news
NDORMS team awarded the International Dupuytren Award
12 November 2019
Dissecting TNF signalling in inflammatory disease
28 October 2019
NDORMS careers event: transitioning from postdoc to PI
23 October 2019